Who makes Eductyl suppository?

Eductyl suppository is developed by Laboratoires Techni Pharma.

What development phase is Eductyl suppository in?

Eductyl suppository is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Eductyl suppository

Laboratoires Techni Pharma · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Eductyl suppository
Sponsor	Laboratoires Techni Pharma
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study Assessing the Efficacy of Eductyl® for the Treatment of Patients With Dyschesia (PHASE4)
Efficacy of Eductyl® Versus Placebo for Treatment of Dyschesia (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Eductyl suppository CI brief — competitive landscape report
Eductyl suppository updates RSS · CI watch RSS
Laboratoires Techni Pharma portfolio CI